Log in
Enquire now
‌

US Patent 7884262 Modified DMO enzyme and methods of its use

Patent 7884262 was granted and assigned to Monsanto on February, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Monsanto
Monsanto
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7884262
Patent Inventor Names
Donald P. Weeks0
Razvan Dumitru0
Stanislaw Flasinski0
Thomas E. Clemente0
Paul C. C. Feng0
Date of Patent
February 8, 2011
Patent Application Number
11758657
Date Filed
June 5, 2007
Patent Citations Received
‌
US Patent 12089555 Soybean variety 01091725
0
‌
US Patent 11930769 Soybean variety 01091763
0
‌
US Patent 11963509 Soybean variety 01091775
0
‌
US Patent 11985949 Soybean variety 01091555
0
‌
US Patent 11987798 Transgenic maize event MON 87419 and methods of use thereof
0
‌
US Patent 11997978 Soybean variety 01083711
0
‌
US Patent 12004474 Soybean variety 01091721
0
‌
US Patent 12004475 Soybean variety 01091767
0
...
Patent Primary Examiner
‌
Eileen B O Hara
Patent abstract

The invention provides a modified variant of dicamba monooxygenase (DMO). The invention relates to the unexpected finding that cells expressing this DMO exhibit high levels of tolerance to the herbicide dicamba. Compositions comprising DMO-encoding nucleic acids and methods of use are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7884262 Modified DMO enzyme and methods of its use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.